25th Mar 2025 10:15 am |
PRN |
Holding(s) in Company |
14th Mar 2025 7:00 am |
PRN |
RBC Capital Markets initiates research coverage |
7th Mar 2025 7:00 am |
PRN |
Employee Long Term Incentive Plan and Issue of Equity |
3rd Mar 2025 4:37 pm |
PRN |
Director's Dealing |
8th Jan 2025 7:00 am |
PRN |
Appointment of Chief Commercial Officer |
17th Dec 2024 7:00 am |
PRN |
Directorate Change |
29th Nov 2024 12:30 pm |
PRN |
Director's Dealing |
19th Nov 2024 2:15 pm |
PRN |
Director's Dealing |
15th Nov 2024 5:31 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 5:30 pm |
PRN |
Holding(s) in Company |
15th Nov 2024 7:00 am |
PRN |
Holding(s) in Company |
14th Nov 2024 7:00 am |
PRN |
Appointment of Joint Corporate Broker |
12th Nov 2024 7:00 am |
PRN |
Completion of Strategic Investment |
3rd Oct 2024 1:25 pm |
PRN |
Holding(s) in Company |
3rd Oct 2024 1:25 pm |
PRN |
Holding(s) in Company |
27th Sep 2024 7:00 am |
PRN |
Half-year Report |
9th Sep 2024 7:00 am |
PRN |
Update re Equity Issuance, Secondary Sale and the board |
8th Aug 2024 3:37 pm |
PRN |
Strategic Advisory Board & Appointment of Director |
29th Jul 2024 4:31 pm |
PRN |
£40.0m Equity Issuance and £29.4m Secondary Sale |
18th Jul 2024 7:00 am |
PRN |
Employee Long Term Incentive Plan and Issue of Equity |
28th Jun 2024 3:45 pm |
PRN |
Result of AGM |
11th Jun 2024 2:42 pm |
PRN |
Holding(s) in Company |
11th Jun 2024 7:00 am |
PRN |
Holding(s) in Company |
11th Jun 2024 7:00 am |
PRN |
Holding(s) in Company |
11th Jun 2024 7:00 am |
PRN |
Holding(s) in Company |
5th Jun 2024 7:00 am |
PRN |
Final Results and Notice of AGM |
30th May 2024 3:30 pm |
PRN |
Holding(s) in Company |
10th Apr 2024 7:00 am |
PRN |
4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program |
21st Mar 2024 7:00 am |
PRN |
4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine |
1st Mar 2024 7:00 am |
PRN |
4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence |
6th Feb 2024 7:01 am |
PRN |
Holding(s) in Company |